These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29117432)

  • 1. Gas Chromatography Mass Spectrometry (GC-MS) for Identification of Designer Stimulants Including 2C Amines, NBOMe Compounds, and Cathinones in Urine.
    Ketha H; Webb M; Clayton L; Li S
    Curr Protoc Toxicol; 2017 Nov; 74():4.43.1-4.43.10. PubMed ID: 29117432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs.
    Westphal F; Girreser U; Waldmüller D
    Drug Test Anal; 2016 Sep; 8(9):910-9. PubMed ID: 26606897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe.
    Liu C; Jia W; Qian Z; Li T; Hua Z
    Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric properties of N-(2-methoxybenzyl)-2-(2,4,6-trimethoxyphenyl)ethanamine (2,4,6-TMPEA-NBOMe), a new representative of designer drugs of NBOMe series and derivatives thereof.
    Shevyrin V; Kupriyanova O; Lebedev AT; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y; Sadykova R
    J Mass Spectrom; 2016 Oct; 51(10):969-979. PubMed ID: 27388323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry.
    Gwak S; Arroyo-Mora LE; Almirall JR
    Drug Test Anal; 2015 Feb; 7(2):121-30. PubMed ID: 24827678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n).
    Wink CS; Meyer MR; Braun T; Turcant A; Maurer HH
    Anal Bioanal Chem; 2015 Jan; 407(3):831-43. PubMed ID: 25120185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
    Vorce SP; Sklerov JH
    J Anal Toxicol; 2004 Sep; 28(6):407-10. PubMed ID: 15516287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
    Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
    Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Theobald DS; Staack RF; Puetz M; Maurer HH
    J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and simple procedure for the determination of cathinones, amphetamine-like stimulants and other new psychoactive substances in blood and urine by GC-MS.
    Mercieca G; Odoardi S; Cassar M; Strano Rossi S
    J Pharm Biomed Anal; 2018 Feb; 149():494-501. PubMed ID: 29175556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
    Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
    J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-beta- phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques.
    Theobald DS; Maurer HH
    J Mass Spectrom; 2006 Nov; 41(11):1509-19. PubMed ID: 17103384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2,5-dimethoxy-beta-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques.
    Theobald DS; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 842(2):76-90. PubMed ID: 16600701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
    Habrdova V; Peters FT; Theobald DS; Maurer HH
    J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
    Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
    Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine.
    Uralets V; Rana S; Morgan S; Ross W
    J Anal Toxicol; 2014 Jun; 38(5):233-41. PubMed ID: 24668489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of gas chromatography-tandem mass spectrometry for the determination of amphetamine-type stimulants in blood and urine.
    Woźniak MK; Wiergowski M; Aszyk J; Kubica P; Namieśnik J; Biziuk M
    J Pharm Biomed Anal; 2018 Jan; 148():58-64. PubMed ID: 28957720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.